A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis

NCT02311881 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

960

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Paracetamol 1000 mg SR tablets
DRUG: Paracetamol 665 mg SR tablets
DRUG: Placebo

Sponsor

GlaxoSmithKline